Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis
Top Cited Papers
- 11 April 2016
- journal article
- other
- Published by Springer Science and Business Media LLC in Acta Neuropathologica
- Vol. 132 (1), 149-151
- https://doi.org/10.1007/s00401-016-1574-9
Abstract
No abstract availableFunding Information
- IZKF Münster (Ha3/019/15)
- KinderKrebsInitiative Buchholz Holm-Seppensen.
This publication has 9 references indexed in Scilit:
- Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer LandscapesCancer Cell, 2016
- Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and SarcomasThe American Journal of Surgical Pathology, 2015
- Anaplastic chordoma with loss of INI1 and brachyury expression in a 2-year-old girlClinical Neuropathology, 2014
- Prognostic value of MIB-1, p53, epidermal growth factor receptor, and INI1 in childhood chordomasNeuro-Oncology, 2013
- Bone Involvement in Atypical Teratoid/Rhabdoid Tumors of the CNSAmerican Journal of Neuroradiology, 2013
- Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletionsLaboratory Investigation, 2012
- Recurrent Chromosomal Copy Number Alterations in Sporadic ChordomasPLOS ONE, 2011
- Loss of SMARCB1/INI1 expression in poorly differentiated chordomasActa Neuropathologica, 2010
- Base of Skull Chordomas in Children and AdolescentsThe American Journal of Surgical Pathology, 2006